Apolipoprotein E: A pharmacogenetic target for the treatment of Alzheimer's disease

Molecular Diagnosis

Volumn 4, Issue 4, 1999, Pages 335-341

  Poirier, Judes ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Alzheimer's disease; Apolipoprotein E; Cholesterol; Cholinergic activity; Lipids; Memory

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; FATTY ACID; LIPID; PHOSPHOLIPID;

ALZHEIMER DISEASE; BINDING SITE; DRUG RESPONSE; ENZYME ACTIVITY; HUMAN; LIPID TRANSPORT; LIPOPROTEIN BLOOD LEVEL; PHARMACOGENETICS; REVIEW;

EID: 0033403325     PISSN: 10848592     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1084-8592(99)80010-1     Document Type: Article

References (2)

1. Boyles JK, Zoellner CD, Anderson LJ, et al.: A role for apolipoprotein E, apolipoprotein A-l, and low-density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve. J Clin Invest 1989;83:1015-1031
2. Poirier J, Hess M, May PC, Finch CE: Cloning of hippocampal poly(A+) RNA sequences that increase after entorhinal cortex lesion in adult rat. Mol Brain Res 1991;9:191-195